Purple Biotech (PPBT) Return on Capital Employed Growth (1y) (2016 - 2026)
Purple Biotech (PPBT) Return on Capital Employed Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
16,829.00 |
| 10 |
Purple Biotech |
242.86 Mn |
236.43 Mn |
- |
22,433.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
22,433.00 |
| Dec 31, 2025 |
9,900.00 |
| Sep 30, 2025 |
-3,780.00 |
| Jun 30, 2025 |
-4,565.00 |
| Mar 31, 2025 |
-4,050.00 |
| Dec 31, 2024 |
-2,896.00 |
| Sep 30, 2024 |
-175.00 |
| Jun 30, 2024 |
1,526.00 |
| Mar 31, 2024 |
2,210.00 |
| Dec 31, 2023 |
1,784.00 |
| Sep 30, 2023 |
1,767.00 |
| Jun 30, 2023 |
1,614.00 |
| Mar 31, 2023 |
1,160.00 |
| Dec 31, 2022 |
1,914.00 |
| Sep 30, 2022 |
829.00 |
| Jun 30, 2022 |
283.00 |
| Mar 31, 2022 |
227.00 |
| Dec 31, 2021 |
53.00 |
| Dec 31, 2020 |
-13,625.00 |
| Dec 31, 2019 |
654.00 |
